购物车
全部删除
您的购物车当前为空
LLS30 is an allosteric inhibitor of Galectin-1 (Gal-1). LLS30 decreases Gal-1 binding affinity to its binding partners, and potentially overcomes metastatic castration-resistant prostate cancer (mCRPC).

LLS30 is an allosteric inhibitor of Galectin-1 (Gal-1). LLS30 decreases Gal-1 binding affinity to its binding partners, and potentially overcomes metastatic castration-resistant prostate cancer (mCRPC).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 17,500 | 10-14周 | |
| 50 mg | ¥ 26,950 | 10-14周 | |
| 100 mg | ¥ 43,100 | 10-14周 |
| 产品描述 | LLS30 is an allosteric inhibitor of Galectin-1 (Gal-1). LLS30 decreases Gal-1 binding affinity to its binding partners, and potentially overcomes metastatic castration-resistant prostate cancer (mCRPC). |
| 分子量 | 701.47 |
| 分子式 | C34H33Cl4N5O3 |
| CAS No. | 2138367-58-3 |
| Smiles | C(N1C(=NC=2C1=CC=C(C(NCC3=CC(Cl)=C(Cl)C=C3)CC(N)=O)C2)C4=CC=C(N(CCO)CCO)C=C4)C5=CC(Cl)=C(Cl)C=C5 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多